IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Erythrocyte Complement Receptor 1 and Alzheimer Disease
This study has been completed.
Sponsor:
CHU de Reims
Information provided by (Responsible Party):
CHU de Reims
ClinicalTrials.gov Identifier:
NCT01565434
First received: March 26, 2012
Last updated: June 8, 2016
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Main objective: investigate whether a functional polymorphism of CR1 (length, number of binding sites in C4b C3b, erythrocyte density, rate of soluble CR1 ...) so determined genetic or acquired, is a susceptibility factor for the disease Alzheimer's.
| Condition | Intervention |
|---|---|
| Alzheimer Disease | Other: CR1 impact |
| Study Type: | Interventional |
| Study Design: | Primary Purpose: Screening |
Resource links provided by NLM:
Genetics Home Reference related topics:
Alzheimer disease
MedlinePlus related topics:
Alzheimer's Disease
U.S. FDA Resources
Further study details as provided by CHU de Reims:
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- caucasians people with a Alzheimer dementia defined on DSMIV criteria for patients and without Alzheimer disease for control subjects
Exclusion Criteria:
- diseases modifying CR1 physiology
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01565434
Please refer to this study by its ClinicalTrials.gov identifier: NCT01565434
Locations
| France | |
| CHU de REIMS | |
| Reims, France, 51092 | |
Sponsors and Collaborators
CHU de Reims
More Information
| Responsible Party: | CHU de Reims |
| ClinicalTrials.gov Identifier: | NCT01565434 History of Changes |
| Other Study ID Numbers: |
PA11014 |
| Study First Received: | March 26, 2012 |
| Last Updated: | June 8, 2016 |
Additional relevant MeSH terms:
|
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on August 18, 2017